AI-engineered nasal spray antiviral platform developed to block flu and COVID-19
byThe Korea Advanced Institute of Science and Technology (KAIST)Overall schematic on the development of intranasal nanoliposomes delivering IFN-λ (NLp@IFN-λ) for antiviral therapy. Credit:Biomaterials
Updated on: January 09,2026
AI-engineered nasal spray antiviral platform developed to block flu and COVID-19
byThe Korea Advanced Institute of Science and Technology (KAIST)Overall schematic on the development of intranasal nanoliposomes delivering IFN-λ (NLp@IFN-λ) for antiviral therapy. Credit:Biomaterials
Updated on:January 09,2026
